175 related articles for article (PubMed ID: 30276443)
21. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
22. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
[TBL] [Abstract][Full Text] [Related]
23. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
24. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
Braicu C; Raduly L; Morar-Bolba G; Cojocneanu R; Jurj A; Pop LA; Pileczki V; Ciocan C; Moldovan A; Irimie A; Eniu A; Achimas-Cadariu P; Paradiso A; Berindan-Neagoe I
J Exp Clin Cancer Res; 2018 Oct; 37(1):257. PubMed ID: 30342533
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
29. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
30. Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response.
Xing AY; Wang B; Li YH; Chen X; Wang YW; Liu HT; Gao P
Pathol Oncol Res; 2021; 27():1609753. PubMed ID: 34257614
[No Abstract] [Full Text] [Related]
31. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
McGuire A; Brown JA; Kerin MJ
Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
[TBL] [Abstract][Full Text] [Related]
32. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
35. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
[TBL] [Abstract][Full Text] [Related]
36. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
37. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
38. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
Kashyap D; Kaur H
Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
40. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]